glp 1 injection or pill Comparing Ozempic, Wegovy and Other GLP-1 Drugs What does the science say

Schedule a consultation today!

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings

Sus bacterias intestinales producen de forma natural GLP-1, la misma hormona que imita Ozempic

President Trump hailed his deal with pharma companies on GLP-1 drug pricing

Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection